Mallinckrodt (MNK) Mentioned Cautiously at Citron Research
Tweet
Share
E-mail
Get Alerts MNK Hot Sheet
Join SI Premium – FREE
(Updated - November 9, 2015 1:57 PM EST)
Mallinckrodt (NYSE: MNK) was mentioned cautiously at Citron Research. Citron said the stock has more downside than Valeant Pharma (NYSE: VRX).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Softbank Group Plans ¥1 Trillion Retail Bond Sale - Bloomberg
- Scorpion Capital says short Twist Biosciences
- Deere conference call: 2027 orders up mid-single digits from last year)
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, Short Sales, Trader Talk, Trading HaltsRelated Entities
Citron ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
